semaglutide shortage update 🚨 FDA Ends The FDA has officially declared an end to the shortage of semaglutide, the active ingredient in the popular medications Ozempic and Wegovy. This announcement signals a significant Semaglutide and Tirzepatide No Longer

Acute kidney injury has occurred, often in the context of severe dehydration from gastrointestinal side effects, emphasising the importance of maintaining adequate hydration

It typically presents as sudden, painless vision loss and may be permanent

[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Neeland IJ, et al

My goal with this episode is to give you the full context the science, the data, the real-world experience so you can decide if it makes sense for you

In Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN-6) trial involving 3,297 patients (baseline HbA1c, 8.7%

Ongoing, forceful vomiting suggests overdosing or a serious adverse reaction